SRCAP gene

Diagnosis usually begins when a pediatrician notices distinct physical features, such as a prominent forehead, wide mouth, and short stature, alongside delayed speech and bone age. Because the facial features can be subtle or change with age, clinicians often order genetic testing. This typically involves whole exome sequencing or a targeted gene panel that specifically looks for mutations in the SRCAP gene. Confirming a pathogenic variant in SRCAP is the gold standard for diagnosis, distinguishing it from other conditions that cause short stature or developmental delay. Are SRCAP-related mutations inherited from parents, or do they occur spontaneously?::Most cases of Floating-Harbor syndrome caused by SRCAP mutations are de novo, meaning they occur as a new mutation in the child and are not present in either parent. This suggests that the condition is not typically inherited in a family. However, because the exact mechanism of inheritance is still being studied, genetic counseling is recommended for parents to understand the recurrence risk for future pregnancies, which is generally considered low but not zero due to the possibility of germline mosaicism in one of the parents. What specific developmental milestones are most commonly delayed in children with SRCAP mutations?::Children with SRCAP mutations often experience significant delays in speech and language development, which is frequently one of the earliest noticeable signs. They may also show delays in motor skills, such as walking or fine motor coordination. Additionally, there is often a delay in bone maturation, known as delayed bone age, which means their skeletal development lags behind their chronological age. While many children have normal or near-normal intelligence, the combination of speech delay and short stature often prompts further medical evaluation. Is there a specific treatment or therapy that can reverse the effects of SRCAP mutations?::There is currently no cure for the genetic mutation itself, and treatment is supportive and focuses on managing symptoms. Early intervention is critical, particularly speech therapy to address language delays and occupational or physical therapy to support motor development. Endocrinologists may monitor growth and bone age to determine if growth hormone therapy or other interventions are appropriate, although the response to growth hormone in Floating-Harbor syndrome can be variable. Regular monitoring by a multidisciplinary team ensures that developmental needs are met as the child grows.